ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

24 hedge funds and large institutions have $36.7M invested in Alpine Immune Sciences, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$853K
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$90K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$447K
4
LRIA
4
Leonard Rickey Investment Advisors
Washington
$42K
5
RJA
5
Raymond James & Associates
Florida
$66K

Top Sellers

1
DM
1
Deerfield Management
New York
$1.75M
2
BCM
2
Bridgeway Capital Management
Texas
$0
3
BI
3
BVF Inc
California
$4.85M
4
Victory Capital Management
4
Victory Capital Management
Texas
$552K
5
HP
5
Hikari Power
Japan
$511K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
Bank of America
27
Bank of America
North Carolina
$0 14 +14 New
1
2